
Meixiao Long
Physician · Ohio State University College of Medicine
Credentials: · · · · · ·
History
- 2013–2014
THE KINGS COLLEGE

- 1992–1996
Doctor of Medicine
Research
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Blood · 2016 · 411 citations
Immunity · 2009 · First of 5 authors · 341 citations
Ibrutinib treatment improves T cell number and function in CLL patients
Journal of Clinical Investigation · 2017 · First of 20 authors · 340 citations
- JB
16 papers

10 papers

10 papers

8 papers
- MX
7 papers · 3 as a resident

6 papers
- KL
6 papers

5 papers
Clinical trials
- 2017–2027
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology



